Non interventional drug studies in oncology: Why we need them?

Divya Mishra1, Jesal Vora

  • 1Division of Medical and Research, Pfizer Limited Patel Estate, Off S.V. Road, Jogeshwari (West), Mumbai - 400 102, Maharashtra, India.

Insights

Non-interventional drug studies in oncology are crucial for validating real-world treatment effectiveness. These studies bridge the gap between controlled trials and clinical practice, enhancing drug safety and efficacy insights.

Area of Science:

  • Oncology
  • Clinical Pharmacology
  • Real-world Evidence

Background:

  • Oncology drug development faces challenges due to patient heterogeneity.
  • Pivotal Phase III Randomized Controlled Trials (RCTs) often use highly selected populations, limiting generalizability.
  • Physicians require real-world data to inform treatment decisions for diverse patient groups.

Purpose of the Study:

  • To highlight the importance of non-interventional drug studies in oncology.
  • To assess the external validity of controlled trial findings in real-world settings.
  • To explore the value of these studies in hypothesis generation and effective conduct.

Main Methods:

  • Discussion of the role of non-interventional studies post-marketing authorization.
  • Analysis of how these studies test the external validity of RCTs.
  • Outline of practical steps for conducting effective non-interventional drug studies.

Main Results:

  • Non-interventional studies are vital for assessing real-world drug performance.
  • These studies complement RCTs by evaluating outcomes in broader patient populations.
  • They provide valuable data for hypothesis generation and refining clinical practice.

Conclusions:

  • Non-interventional studies are essential for understanding drug effectiveness in routine oncology care.
  • They bridge the gap between internal validity from RCTs and external validity in clinical practice.
  • Effective conduct of these studies is key to maximizing their value in oncology research.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...